- Did you mean
- performed
Search results - 7 results
Clinical performance of the novel full-genotyping OncoPredict HPV Quantitative Typing assay using the VALGENT framework.
acid extraction and PCR inhibition are included in the assay. Clinical performance of OncoPredict HPV QT test was assessed as part of the “Validation of HPV Genotyping Tests” (VALGENT-2) framework, ...
Factors influencing SARS-CoV-2 infection rate in Belgian nursing homes’ residents during the first wave of COVID-19 pandemic
of beds and staff, type of beds (level of dependency of residents) and ownership (public, private for profit/non-profit institutions). Risk factor analysis was performed using negative binomial ...
Developing evidence-informed indicators to monitor HIV pre-exposure prophylaxis programmes across EU/EEA countries: a multi-stakeholder consensus
pre-exposure prophylaxis (PrEP) programmes between 2016 and 2023. Data on PrEP programmes’performance and effectiveness in reaching those most in need will be needed to assess regional progress in the roll-out ...
Salmonella Durban meningitis: case report and genomics study.
male infant. The first clinical examination was reassuring, but after a few hours, his general state deteriorated. A blood test and a lumbar puncture were therefore performed. The cerebrospinal fluid ...
Factors underlying COVID-19 booster vaccine uptake among fully vaccinated adults in Belgium
was performed in winter of 2021 (age ≥ 18 years) and a second campaign for (age ≥ 50 years) in autumn of 2022. During these campaigns persons were actively invited to get a booster dose against ...
A new data collection system for Epilabo: the network of sentinel laboratories
Nominative or pseudonymized data are processed according to the legal mandate of different stakeholders. Linkage with other data sets is performed through a recoded national identification of social security ...
Factors underlying COVID-19 booster vaccine uptake among fully vaccinated adults in Belgium
individuals who received their primary course. A first COVID-19 vaccine booster campaign was performed in winter of 2021 (age ≥ 18 years) and a second campaign for (age ≥ 50 years) in autumn of 2022. During ...